These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 277216)

  • 1. Oxygen cathode measurements and radiation response in tumour-bearing mice treated with misonidazole.
    Davies RW; Hall WS
    Br J Cancer Suppl; 1978 Jun; 3():154-8. PubMed ID: 277216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The demonstration of in vivo misonidazole tumour toxicity using post radiation hypoxia.
    Gomer CJ; Johnson RJ; Hetzel FW; Lawrence G
    Br J Cancer Suppl; 1978 Jun; 3():228-31. PubMed ID: 277234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
    Murata R; Tsujitani M; Horsman MR
    Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors.
    Raleigh JA; Chou SC; Arteel GE; Horsman MR
    Radiat Res; 1999 May; 151(5):580-9. PubMed ID: 10319731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of misonidazole in combination with radiation dose fractionation.
    Hill RP; Bush RS
    Br J Cancer Suppl; 1978 Jun; 3():255-8. PubMed ID: 277242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
    Ohizumi Y; Murayama C; Maezawa H; Mori T
    Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of local tumour control by misonidazole and hyperthermia.
    Stone HB
    Br J Cancer Suppl; 1978 Jun; 3():178-83. PubMed ID: 277222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oxygen and misonidazole on cell transformation and cell killing in C3H 10T1/2 cells by X rays in vitro.
    Borsa J; Sargent MD; Einspenner M; Azzam EI; Raaphorst GP
    Radiat Res; 1984 Oct; 100(1):96-103. PubMed ID: 6494435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic gain factors for fractionated radiation treatment of spontaneous murine tumors using fast neutrons, photons plus O2(1) or 3 ATA, or photons plus misonidazole.
    Suit HD; Sedlacek R; Silver G; Hsieh CC; Epp ER; Ngo FQ; Roberts WK; Verhey L
    Radiat Res; 1988 Dec; 116(3):482-502. PubMed ID: 3205910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of misonidazole on the radiosensitivity of transplantable transitional cell bladder carcinoma in mice.
    Hampel N; Persky L
    Invest Urol; 1981 Jul; 19(1):14-6. PubMed ID: 7251317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies in radiosensitizing effects of misonidazole and SR-2508 on experimental animal tumors].
    Ono K; Takahashi M; Hamanaka D; Hiraoka M; Nishidai T; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Feb; 43(2):370-6. PubMed ID: 6223274
    [No Abstract]   [Full Text] [Related]  

  • 12. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR; Overgaard J
    Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of hyperbaric oxygen and misonidazole in fractionated irradiation of murine tumors.
    Suit HD; Maimonis P; Michaels HB; Sedlacek R
    Radiat Res; 1981 Aug; 87(2):360-7. PubMed ID: 7268001
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of misonidazole during continuous low dose rate irradiation.
    Fu KK; Hurst S; Begg AC; Brown JM
    Cancer Clin Trials; 1980; 3(3):257-65. PubMed ID: 7438323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT6 mouse mammary tumour cells in vivo and in vitro.
    Rockwell S
    Br J Cancer Suppl; 1978 Jun; 3():212-5. PubMed ID: 277230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour.
    Sheldon PW; Fowler JF
    Br J Cancer Suppl; 1978 Jun; 3():242-5. PubMed ID: 277239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations.
    Grdina DJ; Sigdestad CP; Jovonovich JA
    Cancer Clin Trials; 1980; 3(2):149-54. PubMed ID: 7428138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
    Murata R; Horsman MR
    Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response.
    Horsman MR; Nielsen T; Østergaard L; Overgaard J
    Acta Oncol; 2006; 45(7):876-80. PubMed ID: 16982553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of misonidazole, microwave hyperthermia, and X-rays on the in vivo sister chromatid exchanges and chromosomal abnormalities of the dbrB tumor and on the survival of its host.
    Banerjee R; Goldfeder A; Mitra J
    Cancer Res; 1983 May; 43(5):2210-5. PubMed ID: 6831443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.